A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency
- First Posted Date
- 2017-05-09
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT03145831
- Locations
- 🇺🇸
Eric Humphriss, Menlo Park, California, United States
Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD)
- First Posted Date
- 2016-03-25
- Last Posted Date
- 2023-04-13
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT02719990
Versartis International Trial in Adults With Long-Acting Growth Hormone
- First Posted Date
- 2015-08-18
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT02526420
- Locations
- 🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇦🇺St Vincent's Hospital, Fitzroy, Victoria, Australia
Versartis Trial in Pre-pubertal Japanese Children With Growth Hormone Deficiency (GHD) to Assess Long-Acting Growth Hormone (Somavaratan, VRS-317)
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2015-04-09
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT02413138
- Locations
- 🇯🇵
Hokkaido University Hospital, Sapporo, Japan
Long-Acting Growth Hormone in Children Compared to Daily rhGH
- First Posted Date
- 2015-01-15
- Last Posted Date
- 2022-12-30
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 138
- Registration Number
- NCT02339090
Versartis Long-Term Safety Study of Somavaratan
- First Posted Date
- 2014-02-21
- Last Posted Date
- 2018-03-09
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 385
- Registration Number
- NCT02068521
Versartis Trial in Children to Assess Long-Acting Growth Hormone
Phase 1
Completed
- Conditions
- First Posted Date
- 2012-10-31
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT01718041
VRS-317 in Adult Subjects With Growth Hormone Deficiency
- First Posted Date
- 2011-05-24
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Versartis Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT01359488
- Locations
- 🇺🇸
Diabetes and Glandular Disease Clinic, San Antonio, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath